Reducing Delays in TSC Treatment Through Better Care Coordination

For patients with Tuberous Sclerosis Complex (TSC), starting therapy often requires coordination across providers, payers, pharmacies, caregivers, and field teams. When communication breaks down or administrative barriers occur, treatment delays can follow.

Epilepsy and seizure disorder are among the most common neurologic manifestations of TSC and have been shown to negatively impact quality of life for patients and families while increasing healthcare utilization and indirect costs (PubMed).

Timely access to therapy depends on more than clinical decisions alone. Early intervention, medication adherence, financial support, and coordination across care teams can all improve symptom control, slow disease progression, and support overall better outcomes.

Where Delays Commonly Happen

Access delays in TSC care often stem from inconsistencies among multiple stakeholders during the initiation and follow-through phases of treatment.

Common friction points include:

• Incomplete Clinical Documentation
• Misaligned Prior Authorization Submissions
• Fragmented Pharmacy Coordination
• Financial Barriers and Coverage Uncertainty
• Limited Ongoing Patient Support

The Role of Coordinated Specialty Support

Improving access requires alignment across providers, payers, pharmacies, patients, and field teams.

Effective coordination includes:

• Complete Clinical Documentation – clear diagnosis, prior therapies, and treatment outcomes reduce approval delays.
• Streamline Prior Authorization Workflows – a centralized point of contact and timely responses during payer review improve efficiency.
• Specialty Pharmacy Alignment – partners experienced in rare disease and neurology can help maintain prescription visibility, confirm payer requirements, and support consistent follow-up.
• Early Financial Support Planning – benefits verification, financial assistance screening, and proactive communication about out-of-pocket costs can help prevent therapy disruptions.

Supporting Patients Beyond Approval

Access to TSC therapy doesn’t end with approval. Ongoing patient education, medication adherence support, financial guidance, and proactive follow-up and monitoring all contribute to long-term treatment success and continuity of care.

Improving access to TSC care depends on coordinated communication, aligned teams, and consistent patient support throughout the treatment journey.

Download the TSC Access Guide for Neurology & Field Teams to learn more about reducing delays and supporting faster access to therapy.